Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Buy
3,857
+70
+2% +$16.9K 0.5% 37
2026
Q2
$732K Sell
3,787
-241
-6% -$42K 0.34% 48
2026
Q1
$687K Sell
4,028
-274
-6% -$53.5K 0.34% 50
2025
Q4
$970K Sell
4,302
-200
-4% -$43.5K 0.48% 39
2025
Q3
$855K Buy
4,502
+315
+8% +$57.3K 0.44% 42
2025
Q2
$660K Buy
4,187
+619
+17% +$93.2K 0.35% 49
2025
Q1
$629K Buy
3,568
+197
+6% +$38.2K 0.35% 46
2024
Q4
$662K Buy
3,371
+25
+0.7% +$5.27K 0.38% 45
2024
Q3
$793K Buy
3,346
+35
+1% +$8.26K 0.44% 44
2024
Q2
$700K Sell
3,311
-33
-1% -$7.5K 0.42% 42
2024
Q1
$846K Sell
3,344
-268
-7% -$62.6K 0.5% 38
2023
Q4
$836K Buy
+3,612
New +$742K 0.55% 41

Other funds holding IQV

Birchbrook's IQV Position: Q3 2026 in Review

Birchbrook increased its IQVIA (IQV) stake by 1.8% in Q3 2026, buying an estimated $16.9K and bringing the position to 3,857 shares worth $1.04M. The position accounts for 0.5% of the portfolio, ranked #37.

Birchbrook first reported a position in IQV in Q4 2023 and has held it in 12 quarters since. 412 funds tracked by Wall St. Rank hold IQV as of Q3 2026.

  • Birchbrook held 3,857 shares of IQVIA worth $1.04M as of Q3 2026.
  • Birchbrook bought 70 IQVIA shares in Q3 2026, an estimated $16.9K.
  • IQVIA made up 0.5% of Birchbrook's portfolio in Q3 2026, its #37 holding.
  • Birchbrook first reported a position in IQVIA in Q4 2023 and has held it in 12 quarters since.
  • 412 funds tracked by Wall St. Rank held IQVIA as of Q3 2026.

Based on Birchbrook's 13F filing for Q3 2026, filed 14 Oct 2026.